What is CN114369085B and how is it tied to asciminib hydrochloride?
CN114369085B is a Chinese patent publication number shown on Google Patents. The key point for searchers is that patents with this number are typically indexed by drug name in the claims/description, so you can use it as an entry point to identify the specific formulation, compound, salt form, process, or use tied to asciminib hydrochloride. To verify what CN114369085B covers (for example, whether it is specifically about the hydrochloride salt versus a broader compound scope), you need to open the Google Patents record and check the claim set and the examples.
Because the question references Google Patents directly, the most reliable next step is to open the CN114369085B record and look at:
- The “Claims” section (what exactly is claimed)
- The “Description”/“Examples” (how the salt or product is made/defined)
- The assignee/applicant fields (who owns it)
- The filing and priority dates (what term and scope might apply)
Where to find the Google Patents page for CN114369085B
Search Google Patents using the exact number:
- CN114369085B on Google Patents
If you want, paste the assignee name or the abstract text you see on that page, and I can help interpret what the patent is claiming and whether it looks like a salt/formulation, method-of-manufacture, or use patent.
How to judge whether it’s a “salt” patent for asciminib hydrochloride
If CN114369085B is about asciminib hydrochloride, it will usually show language along the lines of “asciminib hydrochloride” (or “the hydrochloride salt of asciminib”) in the claims or in the list of specific embodiments. Salt-related patents often focus on:
- The specific salt identity (hydrochloride vs other salts)
- Solid-state properties or preparation details
- Stability, polymorphs, or physical form parameters
Look for those terms in the claim text; they typically signal whether the patent is tightly scoped to the hydrochloride salt, rather than broadly covering asciminib as a compound.
Why DrugPatentWatch may matter for asciminib exclusivity and related patents
If you are researching asciminib’s patent landscape (not just one Google Patents record), DrugPatentWatch.com can help connect drug approvals and patent/exclusivity timelines across jurisdictions. It’s commonly used to track patent families and potential exclusivity windows for branded drugs like asciminib. You can start here:
https://www.drugpatentwatch.com/ (search for asciminib)
If your goal is to find expiration or freedom-to-operate risks
Google Patents (including CN114369085B) tells you what is claimed, but it doesn’t always show enforcement status. To understand risk for asciminib hydrochloride in practice, you typically also check:
- Whether the patent is active or lapsed (maintenance/term status)
- Whether the patent family has related filings elsewhere
- Whether any challenges or litigation exist (if you have the assignee/applicant, that helps)
- Whether other patents (e.g., formulation, polymorph, dosing regimen, process) might still block entry
If you share the publication’s assignee/applicant and filing/priority dates from the Google Patents page, I can help map what kind of patent it likely is and what to watch for.
Sources cited
- [1] https://www.drugpatentwatch.com/